US Patent Number
The present invention provides, among other things, therapeutic compositions and methods that can effectively treat, slow or prevent a neurological disease (e.g., a neurodegenerative disease, e.g., mild cognitive impairment (MCI) or Alzheimer's disease (AD)), in particular, based on therapeutically effective amount of nifedipine, oxidized or nitroso nifedipine derivatives, lactam (e.g., a compound of formula (Ic) or (Ic-i), e.g., NFD-L1), thyroxine (T4), triiodothyronine (T3) and combinations thereof.
The University of Kentucky Research Foundation, Lexington, KY (US)
Lovell, Mark A. and Lynn, Bert C., "Treatment of MCI and Alzheimer's Disease" (2018). Chemistry Faculty Patents. 37.